Angelo Mario Reggiani

Title: Angelo Mario Reggiani: Innovator in Sleep Disorder Treatments

Introduction

Angelo Mario Reggiani is a notable inventor based in Verona, Italy. He has made significant contributions to the field of pharmacology, particularly in the treatment of sleep disorders. His innovative approach has led to the development of a unique patent that addresses a critical health issue.

Latest Patents

Reggiani holds a patent for the "Use of CCK-B receptor antagonists for the treatment of sleep disorders." This patent focuses on the application of CCK-B antagonists, which are designed to improve sleep quality and address various sleep-related issues. His work in this area highlights the potential for new therapeutic options in managing sleep disorders.

Career Highlights

Angelo Mario Reggiani is associated with Glaxo Wellcome Spa, a prominent pharmaceutical company. His role at the company has allowed him to collaborate with other experts in the field, further enhancing his contributions to medical science. His dedication to research and innovation has positioned him as a key figure in the development of new treatments.

Collaborations

Reggiani has worked alongside notable colleagues, including Emiliangelo Ratti and David Gordon Trist. These collaborations have fostered a productive environment for research and development, leading to advancements in the treatment of sleep disorders.

Conclusion

Angelo Mario Reggiani's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His patent for the use of CCK-B receptor antagonists represents a significant step forward in addressing sleep disorders. Through his career and collaborations, he continues to contribute to the advancement of medical treatments.